Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AMBELVIST safely and effectively. See full prescribing information for AMBELVIST. AMBELVIST® (gadoquatrane) injection, for intravenous use Initial U.S. Approval: 2026
Medication labelWhy this: Advisory · dailymed-prescription
AMBELVIST is indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: the central nervous system (brain, spine, and associated tissues) the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system)
- generic_name
- gadoquatrane
- product_names
- Gadoquatrane
- ndc
- 50419-321, 50419-322, 50419-323, 50419-324, 50419-326, 50419-327, 50419-328, 50419-329, 50419-330, 50419-331, 50419-332, 50419-321-01, 50419-321-11, 50419-322-01, 50419-322-11, 50419-323-01, 50419-323-11, 50419-324-01, 50419-324-11, 50419-326-01, 50419-326-11, 50419-327-01, 50419-327-11, 50419-328-01, 50419-328-11, 50419-329-01, 50419-329-11, 50419-330-01, 50419-330-11, 50419-331-01, 50419-331-11, 50419-332-01, 50419-332-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en